Literature DB >> 23218163

Rates of major malformations in infants following exposure to duloxetine during pregnancy: a preliminary report.

Adrienne Einarson, Kelly Smart, Thierry Vial, Orna Diav-Citrin, Laura Yates, Sally Stephens, Alessandra Pistelli, Debra Kennedy, Tricia Taylor, Alice Panchaud, Heli Malm, Gideon Koren, Thomas R Einarson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23218163     DOI： 10.4088/JCP.12l08013

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN： 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  5 in total

1.  Diagnosing and Treating Depression During Pregnancy.

Authors:  Christina L Wichman; Theodore A Stern
Journal:  Prim Care Companion CNS Disord       Date:  2015-04-16

2.  Promise and peril: Dissemination of findings from studies of drugs used in pregnancy and their association with birth defects.

Authors:  Stephen W Patrick; William O Cooper
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2015-07-08

3.  Infant health and neurodevelopmental outcomes following prenatal exposure to duloxetine.

Authors:  Cesario Bellantuono; Alessandra Marini; Chiara Lucarelli
Journal:  Clin Drug Investig       Date:  2013-09       Impact factor: 2.859

4.  Maternal and fetal outcomes following exposure to duloxetine in pregnancy: cohort study.

Authors:  Krista F Huybrechts; Brian T Bateman; Ajinkya Pawar; Lily G Bessette; Helen Mogun; Raisa Levin; Hu Li; Stephen Motsko; Maria Fernanda Scantamburlo Fernandes; Himanshu P Upadhyaya; Sonia Hernandez-Diaz
Journal:  BMJ       Date:  2020-02-19

5.  Exposure to duloxetine during pregnancy and risk of congenital malformations and stillbirth: A nationwide cohort study in Denmark and Sweden.

Authors:  Mikkel Zöllner Ankarfeldt; Janne Petersen; Jon Trærup Andersen; Hu Li; Stephen Paul Motsko; Thomas Fast; Simone Møller Hede; Espen Jimenez-Solem
Journal:  PLoS Med       Date:  2021-11-22       Impact factor: 11.069
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.